RXO IncRXO
Price$21.36

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $6.1B+33.8% YoYTTM through 30 Jun 2026
Net Income -$105MTTM through 30 Jun 2026
Free Cash Flow -$76MTTM through 30 Jun 2026

Margins

Current
Gross Margin14.2%
EBITDA Margin0.5%
Operating Margin-2.0%
Net Margin-1.7%

Returns

-7.0%ROE
-3.2%ROA

Balance Sheet Health

Debt / Equity0.30x
Current Ratio1.27x
Net Debt$426M
Cash & Equivalents$15M

Quality Metrics

Altman Z-Score2.63
Piotroski F-Score3 / 9
FCF Margin-1.2%
Rule of 4011.1
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $5.7B
Diluted EPS-$0.62TTM
'20'21'22'23'24'25
FY2025: $-0.59

Dividend

No dividend

Capital Allocation

Capex Intensity1.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.